Skip to main content
JACC Case Reports logoLink to JACC Case Reports
editorial
. 2022 Nov 29;4(24):101684. doi: 10.1016/j.jaccas.2022.101684

Is Knowledge Always Power?

The Curse of Knowing

Pranav Mankad 1, Kenneth A Ellenbogen 1,
PMCID: PMC9847239  PMID: 36684030

Corresponding Author

graphic file with name fx1.jpg

Key Words: conduction system pacing, left bundle branch pacing


Left bundle branch area pacing (LBBAP) is overall safe, feasible, and a reliable method to achieve physiologic pacing.1, 2, 3, 4 Although His bundle pacing is the ultimate way to achieve physiologic pacing, LBBAP has several advantages over His bundle pacing as the most practical and widely used modality to achieve conduction system pacing. These include larger anatomical target during implantation and, as a result, greater short-term implantation success rate and better short- and intermediate-term lead threshold data.2, 3, 4, 5, 6

During the LBBAP implantation procedure, the septal lead unipolar pacing morphology, ring capture threshold, and occasionally a septogram performed via the delivery sheath are used to confirm the position and depth of the lead into the septum.1,2,7 In this issue of JACC: Case Reports, Batul et al8 demonstrate 2 examples of LBBAP lead implantation where the septogram showed contrast material draining through the lesser cardiac veins into the epicardial coronary venous system during fluoroscopy.

Case 1 demonstrates an example of a septogram performed during a stylet-driven septal lead implantation. There is staining of contrast material adjacent to the lead tip followed by drainage of contrast material through the lesser cardiac veins into the epicardial coronary vessels and the main body of the coronary sinus (CS). Case 2 is an example of deep septal lead implantation using a lumenless lead. There is staining of contrast material adjacent to the ring electrode that drains through septal perforators into the epicardial venous system and ultimately into the main body of the CS. There was no retention of residual contrast material in either case, and echocardiography immediately after the procedure and 3 months later did not show any pericardial effusion. Lead parameters were also stable in both cases at the 3-months follow-up visit.

Owing to the deep transseptal location of the pacing lead, there is a new set of potential complications that are unique to LBBAP as compared with the conventional right ventricular pacing lead. The complication rate during LBBAP lead implantation ranges from 1.63% to 14.1%, as noted in different studies.2,3,9,10 In the largest to date registry-based multicenter observational study, the MELOS (Multicentre European Left Bundle Branch Area Pacing Outcomes Study) study (N = 2,533) of patients who underwent LBBAP, the overall rate of complications specific to the transseptal nature of the pacing lead was 8.3% in the experienced centers. These include, but are not limited to, intraprocedural perforation (3.67%) and delayed perforation (0.08%) into the left ventricular (LV) cavity, acute ST-segment elevation in multiple leads (0.24%), acute coronary syndrome (0.43%), coronary vein fistula (0.28%), coronary artery fistula (0.08%), chest pain 0.98%), and trapping of the LBBAP lead helix (0.43%). Interestingly, the dreaded complication of stroke/transient ischemic attack was not observed in this study, likely because of intraprocedural recognition of perforation into the LV cavity based on tip unipolar impedance drop during implantation and prompt repositioning of the lead. There were also 2 patients (0.08%) with delayed perforation into the LV cavity, however, and it is unclear whether they were receiving anticoagulant therapy. Other complications that are not unique to LBBAP include significant threshold rise from baseline (<1.5%) or increased threshold leading to repeated intervention (0.16%) and lead dislodgment (1.5%), which has been a greater concern with His bundle lead placement.2,3,11

Batul et al8 demonstrate 2 cases of overall benign but potentially anxiety-provoking findings noted during the septogram performed at the time of LBBAP lead implantation. Although coronary arterial or venous fistula is a rare finding, as noted in the MELOS study, this is likely under-reported for various reasons.3 A septogram is not always performed during septal lead placement. When an echocardiogram is performed after LV septal lead placement, the focus is usually on ejection fraction and hemodynamics. Rarely when the question arises whether the septal lead has perforated into the LV cavity, greater attention is paid to the lead position and depth in the septum, and color Doppler is not routinely used. Regardless, the consequences of small coronary arterial or venous fistula during LBBAP lead implantation even if present are unclear. It is possible that the repeated positioning if required with a stylet-driven lead with a larger diameter may be more traumatic than the more commonly used 4.1-F SelectSure 3830 lead (Medtronic); however, this hypothesis would need to be tested in further clinical trials. In this instance, the drainage of contrast material noted was a benign finding, possibly related to forceful injection of the contrast material.

Batul et al8 should be commended for observing and reporting a phenomenon that could possibly have been overlooked. As the LBBAP with deep septal lead implantation is more and more widely adapted worldwide and different methods and tools are being developed to achieve the same physiologic result, having a keen eye for unusual phenomena during the procedure may allow early distinction of a benign from a potentially more consequential finding. Further studies looking at differences in complication rates related to specific type of lead design used at implantation are needed.

Funding Support and Author Disclosures

Dr Ellenbogen has received honoraria for lectures and consulting from Medtronic, Boston Scientific, Biotronik, and Abbott. Dr Mankad has reported that he has no relationships relevant to the contents of this paper to disclose.

Footnotes

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.

References

  • 1.Huang W., Su L., Wu S., et al. A novel pacing strategy with low and stable output: Pacing the left bundle branch immediately beyond the conduction block. Can J Cardiol. 2017;33:1736.e1–1736.e3. doi: 10.1016/j.cjca.2017.09.013. [DOI] [PubMed] [Google Scholar]
  • 2.Padala S.K., Master V.M., Terricabras M., et al. Initial experience, safety, and feasibility of left bundle branch area pacing: A multicenter prospective study. J Am Coll Cardiol EP. 2020;6:1773–1782. doi: 10.1016/j.jacep.2020.07.004. [DOI] [PubMed] [Google Scholar]
  • 3.Jastrzębski M., Kiełbasa G., Cano O., et al. Left bundle branch area pacing outcomes: The multicentre European MELOS study. Eur Heart J. 2022;43:4161–4173. doi: 10.1093/eurheartj/ehac445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Vijayaraman P., Ponnusamy S.S., Cano Ó., et al. Left bundle branch area pacing for cardiac resynchronization therapy: Results from the international LBBAP collaborative study group. J Am Coll Cardiol EP. 2021;7:135–147. doi: 10.1016/j.jacep.2020.08.015. [DOI] [PubMed] [Google Scholar]
  • 5.Su L., Wang S., Wu S., et al. Long-term safety and feasibility of left bundle branch pacing in a large single-center study. Circ Arrhythm Electrophysiol. 2021;14:E009261. doi: 10.1161/CIRCEP.120.009261. [DOI] [PubMed] [Google Scholar]
  • 6.Zhang S., Zhou X., Gold M.R. Left bundle branch pacing: JACC review topic of the week. J Am Coll Cardiol. 2019;74:3039–3049. doi: 10.1016/j.jacc.2019.10.039. [DOI] [PubMed] [Google Scholar]
  • 7.Huang W., Chen X., Su L., Wu S., Xia X., Vijayaraman P. A beginner’s guide to permanent left bundle branch pacing. Heart Rhythm. 2019;16:1791–1796. doi: 10.1016/j.hrthm.2019.06.016. [DOI] [PubMed] [Google Scholar]
  • 8.Batul S.A., Mahajan A., Subzposh F.A., et al. Coronary venous visualization during deep septal lead placement: An unexpected finding. J Am Coll Cardiol Case Rep. 2022;4:101622. doi: 10.1016/j.jaccas.2022.08.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chen X., Wei L., Bai J., et al. Procedure-related complications of left bundle branch pacing: A single-center experience. Front Cardiovasc Med. 2021;8 doi: 10.3389/fcvm.2021.645947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ponnusamy S.S., Basil W., Vijayaraman P. Electrophysiological characteristics of septal perforation during left bundle branch pacing. Hear Rhythm. 2022;19:728–734. doi: 10.1016/j.hrthm.2022.01.018. [DOI] [PubMed] [Google Scholar]
  • 11.Teigeler T., Kolominsky J., Vo C., et al. Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience. Hear Rhythm. 2021;18:743–749. doi: 10.1016/j.hrthm.2020.12.031. [DOI] [PubMed] [Google Scholar]

Articles from JACC Case Reports are provided here courtesy of Elsevier

RESOURCES